51
In band
Moving averages
SMA 200$19.00-2.00%
Company profile
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapies, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. The company is headquartered in Cambridge, Massachusetts.
SectorHealthcare
IndustryBiotechnology
Market cap$1.77B
P/E ratioNone
EPS$-1.57
Beta0.375
Dividend yield0.00%
52-week high$24.68
52-week low$14.68
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 41
VRTX
Vertex Pharmaceuticals Inc
RSI 68
CRSP
CRISPR Therapeutics AG
RSI 48
IOVA
Iovance Biotherapeutics Inc
RSI 30
NTLA
Intellia Therapeutics Inc
RSI 53
GPCR
Structure Therapeutics Inc
RSI 27
NVAX
Novavax Inc
RSI 45
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 53
AUPH
Aurinia Pharmaceuticals Inc
RSI 49
GHRS
GH Research PLC
RSI 48
RSI alerts for SRPT
An email when SRPT closes below RSI 30 or above 70. Nothing else.
Add alertData last updated 13 October 2026 at 9:18 PM EDT